Dr Reddy's

Stocks To Watch: The Nifty futures contract traded on the Singapore Exchange indicates a positive start to domestic equities. The contract was trading at 18,148.50, up 24.5 points or 0.14% from the previous close.Earnings today: Aarti…

Representational image only. | Photo Credit: Special Arrangement Dr. Reddy’s Laboratories (DRL) is acquiring the U.S. generic prescription product portfolio of Australia’s Mayne Pharma Group for $105 million, which includes an upfront cash…

Dr. Reddy’s Laboratories shares gained on Monday in the backdrop of the drugmaker announcing successful completion of a phase-1 study of its proposed biosimilar of tocilizumab for use in the treatment of rheumatoid arthritis. DRL_TC, the…

<!-- -->Dr Reddy's asserted that "the allegations against it lack merit."(Representational)New Delhi: Dr Reddy's Laboratories Ltd on Tuesday said it is among several generic pharmaceutical companies, including Celgene and Bristol…

<!-- -->Dr Reddy's Laboratories reported a consolidated profit after tax (PAT) of Rs 1,113 crore.New Delhi: Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into…

<!-- -->Dr Reddy's initiated the Class III voluntary recall on September 14 this year.(File)New Delhi: Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for…

Last Updated: July 28, 2022, 17:46 ISTDr Reddy's underlying business revenues adjusted for COVID-19 products contribution during last year have grown well.. (Photo: Reuters File)Its revenues during the quarter under discussion were up by 6%…

Proceeds from a settlement pact with British drugmaker lndivior and its strategy of divesting brands to sharpen focus on core products aided pharma major Dr. Reddy’s Laboratories in reporting manifold increase in consolidated net profit to…

Nifty futures on the Singapore Exchange traded 25 points, or 0.16 per cent, higher at 15,334.50, signaling that Dalal Street was headed for a positive start on Friday. After the US Fed announced a 75 basis point hike, the domestic equity…

Given the prevalence of cardiovascular diseases, this acquisition will allow Dr. Reddy’s to make a trusted portfolio of medicines available to the patients Given the prevalence of cardiovascular diseases, this acquisition will allow Dr.…